- Home
- CARM
CARM
Carisma Therapeutics Inc.
as 04-24-2025 11:33am EST
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | PHILADELPHIA |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $0.90 | AVG Volume (30 days): | 254.6K |
| Analyst Decision: | Hold | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.46 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.16 - $1.91 | Next Earning Date: | 05-08-2025 |
| Revenue: | $19,632,000 | Revenue Growth: | 31.59% |
| Revenue Growth (this year): | -12.19% | Revenue Growth (next year): | -46.15% |
Latest Carisma Therapeutics Inc. News
CARM Breaking Stock News: Dive into CARM Ticker-Specific Updates for Smart Investing
Simply Wall St.
22 days ago
Carisma Therapeutics Full Year 2024 Earnings: Misses Expectations
MT Newswires
24 days ago
Carisma Therapeutics Board Approves Revised Operating Plan; Reduces Workforce
PR Newswire
24 days ago
Carisma Therapeutics Provides Corporate Updates
PR Newswire
2 months ago
Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
PR Newswire
3 months ago
Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
MT Newswires
4 months ago
HC Wainwright Downgrades Carisma Therapeutics to Neutral From Buy
MT Newswires
4 months ago
BTIG Downgrades Carisma Therapeutics to Neutral From Buy
PR Newswire
5 months ago
Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline
Compare CARM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CARM Carisma Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.